Thromboxane-A synthase (TBXAS1)

The protein contains 533 amino acids for an estimated molecular weight of 60518 Da.

 

Catalyzes the conversion of prostaglandin H2 (PGH2) to thromboxane A2 (TXA2), a potent inducer of blood vessel constriction and platelet aggregation (PubMed:8436233, PubMed:11297515, PubMed:9873013, PubMed:11097184, PubMed:24009185, PubMed:22735388). Cleaves also PGH2 to 12-hydroxy-heptadecatrienoicacid (12-HHT) and malondialdehyde, which is known to act as a mediator of DNA damage. 12-HHT and malondialdehyde are formed stoichiometrically in the same amounts as TXA2 (PubMed:11297515, PubMed:9873013, PubMed:22735388). Additionally, displays dehydratase activity, toward (15S)-hydroperoxy-(5Z,8Z,11Z,13E)-eicosatetraenoate (15(S)-HPETE) producing 15-KETE and 15-HETE (PubMed:17459323). (updated: Feb. 10, 2021)

Protein identification was indicated in the following studies:

  1. D'Alessandro and co-workers. (2017) Red blood cell proteomics update: is there more to discover? Blood Transfus. 15(2), 182-187.

Methods

The following articles were analysed to gather the proteome content of erythrocytes.

The gene or protein list provided in the studies were processed using the ID mapping API of Uniprot in September 2018. The number of proteins identified and mapped without ambiguity in these studies is indicated below.
Only Swiss-Prot entries (reviewed) were considered for protein evidence assignation.

PublicationIdentification 1Uniprot mapping 2Not mapped /
Obsolete
TrEMBLSwiss-Prot
Goodman (2013)2289 (gene list)227853205992269
Lange (2014)123412347281224
Hegedus (2015)2638262202352387
Wilson (2016)165815281702911068
d'Alessandro (2017)18261817201815
Bryk (2017)20902060101081942
Chu (2018)18531804553621387

1 as available in the article and/or in supplementary material
2 uniprot mapping returns all protein isoforms as one entry

The compilation of older studies can be retrieved from the Red Blood Cell Collection database.

The data and differentiation stages presented below come from the proteomic study and analysis performed by our partners of the GReX consortium, more details are available in their published work.

No sequence conservation computed yet.

This protein is predicted to be membranous by TOPCONS.


Interpro domains
Total structural coverage: 0%
Model score: 37

(right-click above to access to more options from the contextual menu)

VariantDescription
allele CYP5A1*2
dbSNP:rs13306050
dbSNP:rs4529
GHDD
a breast cancer sample
dbSNP:rs8192833
allele CYP5A1*3
dbSNP:rs6137
allele CYP5A1*4
The KM value is about 1.5 higher for PEG2
dbSNP:rs5770
dbSNP:rs5771
dbSNP:rs6140
allele CYP5A1*5
dbSNP:rs4529
dbSNP:rs3735354
dbSNP:rs3735354
dbSNP:rs5760
GHDD
allele CYP5A1*6
dbSNP:rs5762
dbSNP:rs4526
allele CYP5A1*7
allele CYP5A1*8
allele CYP5A1*9
GHDD
GHDD
dbSNP:rs8192864
dbSNP:rs13306050
dbSNP:rs13306050

No binding partner found

The reference OMIM entry for this protein is 231095

Ghosal hematodiaphyseal dysplasia; ghdd
Ghosal syndrome

A number sign (#) is used with this entry because of evidence that Ghosal heamtodiaphyseal dysplasia (GHDD) can be caused by homozygous mutation in the TBXAS1 gene (274180), which encodes thromboxane synthase (TXAS), on chromosome 7q34.

CLINICAL FEATURES

Ghosal et al. (1988) presented 5 patients with a particular form of diaphyseal dysplasia and refractory anemia. In spite of certain similarities to Camurati-Engelmann disease (131300), major differences were noted. Most notably, in Camurati-Engelmann disease, only the diaphyses are involved, whereas in the disorder described by Ghosal et al. (1988), both diaphyses and metaphyses were affected. Gumruk et al. (1993) described an affected brother and sister, aged 8 and 4 years, respectively, with diaphyseal dysplasia, severe anemia, leukopenia, and thrombocytopenia. The children were the products of a first-cousin marriage. Radiologically, both had wide medullary cavities in the long bones with discrete cortical hyperostosis. Bone marrow was hypocellular. The smooth surface of the long bones showed that there was no periosteal and only endosteal hyperostosis. The presence of anemia and other hematologic abnormalities, and the absence of gait disturbances, muscular involvement, and pain in the limbs also separated the disorder from Camurati-Engelmann disease. Parental consanguinity was present also in the case reported by Ozsoylu (1989). The apparent mode of inheritance as a recessive also distinguishes Ghosal disease from Camurati-Engelmann disease which is a dominant. Elevated levels of IgG and IgA were observed in the cases of Gumruk et al. (1993) and Ozsoylu (1989).

MAPPING

Isidor et al. (2007) performed a genomewide screen in 2 consanguineous families with Ghosal hematodiaphyseal dysplasia from Algeria and Tunisia, respectively, and found that the 5 affected individuals were homozygous at D7S684 and contiguous markers. Two-point linkage analysis between D7S2513 and the disease locus yielded a maximum lod score of 4.21 (theta = 0.0). Haplotype heterozygosity in the Tunisian family narrowed the locus to a 3.84-Mb interval between D7S2560 and AC091742 on chromosome 7q33-q34, a region that encompasses 37 genes.

MOLECULAR GENETICS

In the Algerian and Tunisian families with GHDD studied by Isidor et al. (2007) and in 2 more families of Tunisian and Pakistani origin, Genevieve et al. (2008) identified mutations in the TBXAS1 gene (274180), which encodes thromboxane synthase (TXAS). TXAS, an enzyme of the arachidonic acid cascade, produces thromboxane A2 (TXA2). Platelets from subjects with GHDD showed a specific deficit in arachidonic acid-produced aggregation. They also found that TXAS and TXA2 modulated expression of TNFSF11 (602642) and TNFRSF11B (602643), which encode RANKL and osteoprotegerin (OPG), respectively, in primary cultured osteoblasts. ... More on the omim web site

Subscribe to this protein entry history

Feb. 16, 2021: Protein entry updated
Automatic update: Entry updated from uniprot information.

June 30, 2020: Protein entry updated
Automatic update: OMIM entry 231095 was added.

Feb. 23, 2019: Protein entry updated
Automatic update: comparative model was added.

Feb. 23, 2019: Protein entry updated
Automatic update: model status changed

Oct. 19, 2018: Additional information
Initial protein addition to the database. This entry was referenced in Bryk and co-workers. (2017).